Cargando…
Gene signatures predict biochemical recurrence‐free survival in primary prostate cancer patients after radical therapy
BACKGROUND: This study evaluated the predictive value of gene signatures for biochemical recurrence (BCR) in primary prostate cancer (PCa) patients. METHODS: Clinical features and gene expression profiles of PCa patients were attained from Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (T...
Autores principales: | Su, Qiang, Liu, Zhenyu, Chen, Chi, Gao, Han, Zhu, Yongbei, Wang, Liusu, Pan, Meiqing, Liu, Jiangang, Yang, Xin, Tian, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446568/ https://www.ncbi.nlm.nih.gov/pubmed/34453418 http://dx.doi.org/10.1002/cam4.4092 |
Ejemplares similares
-
GPX2 predicts recurrence-free survival and triggers the Wnt/β-catenin/EMT pathway in prostate cancer
por: Yang, Ming, et al.
Publicado: (2022) -
Signature identification of relapse-related overall survival of early lung adenocarcinoma after radical surgery
por: Han, Peng, et al.
Publicado: (2021) -
Expression of 5‐methylcytosine regulators is highly associated with the clinical phenotypes of prostate cancer and DNMTs expression predicts biochemical recurrence
por: Wang, Lin, et al.
Publicado: (2021) -
Identification of a circadian gene signature that predicts overall survival in lung adenocarcinoma
por: Gao, Xinliang, et al.
Publicado: (2021) -
A genomic-clinical nomogram predicting recurrence-free survival for patients diagnosed with hepatocellular carcinoma
por: Kong, Junjie, et al.
Publicado: (2019)